These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34731115)

  • 1. Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis.
    Gao G; Liu C; Li X; Guan X; Yang X; Qin P
    Medicine (Baltimore); 2021 Oct; 100(41):e27415. PubMed ID: 34731115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
    Tang Y; Wang Y; Wang X; Liu Y; Zheng K
    Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.
    Zheng Z; Liu S; Wang C; Han X
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
    Shen Z; She Q
    Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis.
    Dong X; Gao W; Lv X; Wang Y; Wu Q; Yang Z; Mao G; Xing W
    Dis Markers; 2020; 2020():6723487. PubMed ID: 32300378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA growth arrest-special 5 polymorphisms and predisposition to cancer: A meta-analysis.
    Cai H; Xu W; Zhang X
    Int J Biol Markers; 2020 Dec; 35(4):28-34. PubMed ID: 32996361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
    Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk.
    Zhao S; Liu P; Ruan Z; Li J; Zeng S; Zhong M; Tang L
    J Int Med Res; 2021 Sep; 49(9):3000605211039798. PubMed ID: 34521242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between an insertion/deletion polymorphism in IL-1A gene and cancer risk: a meta-analysis.
    Ma L; Zhou N
    Onco Targets Ther; 2016; 9():1-6. PubMed ID: 26719711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of LncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population.
    Liu CH; Lu YL; Huang HT; Wang CF; Luo HC; Wei GJ; Lei M; Tan T; Wang Y; Huang YY; Wei YS; Lan Y
    J Cell Mol Med; 2021 Apr; 25(7):3548-3559. PubMed ID: 33728802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationships of genetic polymorphisms of the long noncoding RNA growth arrest-specific transcript 5 with uterine cervical cancer.
    Weng SL; Ng SC; Lee YC; Hsiao YH; Hsu CF; Yang SF; Wang PH
    Int J Med Sci; 2020; 17(9):1187-1195. PubMed ID: 32547314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.
    Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M
    DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.
    Li Q; Ma G; Sun S; Xu Y; Wang B
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and cancer risk: a meta-analysis and systematic review.
    Ge YZ; Ge Q; Li MH; Shi GM; Xu X; Xu LW; Xu Z; Lu TZ; Wu R; Zhou LH; Wu JP; Liang K; Dou QL; Zhu JG; Li WC; Jia RP
    Hum Immunol; 2014 Aug; 75(8):827-32. PubMed ID: 24952208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the
    Jiang Y; Lu J; Wu YE; Zhao X; Li L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma.
    Xu L; Xia C; Xue B; Sheng F; Xiong J; Wang S
    J Bone Oncol; 2018 Sep; 12():23-26. PubMed ID: 30013899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
    PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.
    Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
    Int J Med Sci; 2019; 16(11):1424-1429. PubMed ID: 31673232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Li T; Huang H; Liao D; Ling H; Su B; Cai M
    Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variants of lncRNA
    Hsieh MH; Lu HJ; Lin CW; Lee CY; Yang SJ; Wu PH; Chen MK; Yang SF
    J Pers Med; 2021 Apr; 11(5):. PubMed ID: 33925911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.